ECOR: electroCore Company Sales Revenue

Direct delivery of neurostimulators to patients optimizes logistics and costs for electroCore, Inc. (ECOR). The company's sales time series confirms the effectiveness of this strategy, where the value of 0.04 corresponds to the current metric. Revenue growth is based on the closed gammaCore ecosystem with mobile services, as well as the expansion of insurance payouts for the therapy of migraines and neurological pathologies.

Revenue and Sales Volume: electroCore Inc (ECOR) for 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for electroCore Inc (ECOR)

- stock value and consensus price forecast:

Stock Quotes electroCore Medical|ECOR - Consensus Target

- market capitalization information:

Market Value electroCore, Inc.|ECOR - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share electroCore|ECOR - Book Capitalization|Market-to-Book Ratio electrocore.com|ECOR - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

ECOR - Net Income|Expected Net Income electroCore, Inc.|ECOR - P/E Multiple|Projected Price to Earnings Ratio electroCore Medical|ECOR - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple electroCore, Inc.|ECOR - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) electroCore|ECOR - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months electrocore.com|ECOR - Earnings per share growth in current year|Net earnings per share change forecast for next year electroCore, Inc.

- company sales and revenue statistics:

ECOR - Company Revenue|Company Future Sales Volume electroCore Medical|ECOR - P/S Multiple|Market Cap to Future Revenue Ratio electroCore, Inc.

Summary company analysis:ECOR electrocore.com

Sales at electroCore, Inc. (ECOR) reflect the aggregate cash flow from product sales, capturing the net volume of market demand in real time. Investors utilize this metric to assess operational efficiency and promptly identify phases of waning revenue momentum. Analyzing the current sales performance of electroCore, Inc. (ECOR) reveals how the patent protection for vagus nerve stimulators is encountering administrative barriers within the insurance sector. This indicator allows for tracking how successfully electroCore, Inc. (ECOR) overcomes bureaucratic complexities when monetizing its innovations.

Key competitors